Hydroxyzine (Atarax/Vistaril) Detection Time

First-gen antihistamine anxiolytic · Prescription only, unscheduled.

Quick answer

Hydroxyzine (Atarax/Vistaril) is typically detectable in urine for interference ~1–3 days post-dose after any use. It is screened on standard 5-panel, 10-panel, 12-panel drug tests.

Screened on: 5-panel 10-panel 12-panel

Typical cutoff: Not screened; TCA-strip cross-reactivity risk.

Detection window by test type

urine
Any useinterference ~1–3 days post-dose
saliva
Any usen/a
hair
Any usen/a
blood
Any usen/a

Ranges reflect typical published detection windows and vary with dose, frequency, body composition, hydration and the assay used.

Key details

Hydroxyzine is never a target analyte. Structurally antihistamine-TCA adjacent, it can flag tricyclic screens (like diphenhydramine). Confirmations close the loop.

False positives & cross-reactivity

  • TCA-screen cross-reactivity (assay-dependent).

Frequently asked questions

How long does hydroxyzine (atarax/vistaril) stay in your system?

In urine, typical detection is interference ~1–3 days post-dose (any use). Hair can detect use for up to 90 days and saliva/blood windows are usually shorter.

Will hydroxyzine (atarax/vistaril) show up on a standard drug test?

Yes — Hydroxyzine (Atarax/Vistaril) is screened on standard panels (5-panel, 10-panel, 12-panel).

Can anything cause a false positive for hydroxyzine (atarax/vistaril)?

TCA-screen cross-reactivity (assay-dependent).

How accurate are these detection windows?

They are typical ranges from published literature and assay documentation, not guarantees. Clearance depends on dose, frequency, metabolism and the specific test cutoff used.

Need an actual test?
Order online and visit a certified collection site — no doctor's order needed.
Order a Hydroxyzine drug test

Cite this page

DrugPanels. “Hydroxyzine (Atarax/Vistaril) Detection Time.” https://drugpanels.com/detection/hydroxyzine/. Accessed 2026-09-10.

Sources

  • Brahm NC et al., Commonly prescribed medications and potential false-positive drug test results, Mayo Clinic Proceedings 2008 — Mayo Clinic Proceedingspubmed.ncbi.nlm.nih.gov
  • Immunoassay cross-reactivity and validation documentation (FDA 510(k) summaries) — U.S. Food and Drug Administrationaccessdata.fda.gov

Detection windows describe typical ranges from the published literature and assay documentation; individual results vary. See our methodology.

Reviewed for sourcing accuracy against SAMHSA, FDA and peer-reviewed references. Last updated 2026-09-10. Educational information only — not medical or legal advice.